Clinical Trial Update: Behavioral Treatment of Weight Gain in CF [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating a behavioral treatment for weight gain in cystic fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Cystic Fibrosis | Phase 3 | Status: COMPLETED